Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.17 - $1.65 $117,755 - $166,065
-100,646 Reduced 77.68%
28,912 $33,000
Q1 2024

May 13, 2024

BUY
$1.15 - $2.19 $11,675 - $22,235
10,153 Added 8.5%
129,558 $193,000
Q4 2023

Feb 13, 2024

BUY
$0.93 - $2.35 $111,046 - $280,601
119,405 New
119,405 $250,000
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $134,841 - $361,227
41,236 New
41,236 $142,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $171M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.